Introduced in House
Sponsored by Donald G. Davis (D, NC-1)
- INTRODUCED
- COMMITTEEFeb 12, 2025
- PASSED HOUSE
- SENATES. 2617, companion — in committee
- LAW
In committee. Latest action on Feb 12, 2025: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. Its identical companion S. 2617 is in committee. It has 2 cosponsors and 3 recorded actions, and 3 organizations cited it in Q2 2026 lobbying disclosures.
Recent actions
3 totalIntroduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Reported lobbying
| Organization | Filed by | Total Q2 2026 lobbying |
|---|---|---|
| Pharmaceutical Care Management Association | In-house | $3,282,990 |
| America's Health Insurance Plans (ahip) | In-house | $3,010,000 |
| Chronic Care Policy Alliance (CCPA) | In-house | — |
These totals are not spending on this bill. Lobbying is reported per filing, not per issue — each figure is everything the organization reported for the period, across every bill and agency it named. Read it as scale of presence.
